CARDIOVASCULAR DRUGS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
ALIROCUMAB: products 1 to 3 of 3.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Praluent 150mg/mL Inj Sol-Pref PenDIN 02453835 | Limited Use, codes 555 | $273.4500per source unit | Requirements & sourcesBuild cost plan |
| Praluent 300mg/2mL Inj Sol-Pref Pen 2mL Pk (Preservative-Free)DIN 02547732 | Limited Use, codes 555 | $546.9000per source unit | Requirements & sourcesBuild cost plan |
| Praluent 75mg/mL Inj Sol-Pref PenDIN 02453819 | Limited Use, codes 555 | $273.4500per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:00 CARDIOVASCULAR DRUGS.
24:04 Cardiac Drugs.
24:06 Antilipemic Drugs.
24:06:24 PCSK9 Inhibitors.
24:08 Hypotensive Drugs (For Diuretics See 40:28).
24:08:16 Central Alpha-Agonists.
24:12 Vasodilating Drugs.
24:32:08 Angiotensin II Receptor Antagonists.